- Home
- VRAX vs POLA Comparison
VRAX vs POLA Comparison
Compare VRAX & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- POLA
- Stock Information
- Founded
- VRAX 2013
- POLA 1979
- Country
- VRAX United Kingdom
- POLA United States
- Employees
- VRAX N/A
- POLA N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- POLA Industrial Machinery/Components
- Sector
- VRAX Health Care
- POLA Miscellaneous
- Exchange
- VRAX Nasdaq
- POLA Nasdaq
- Market Cap
- VRAX 9.1M
- POLA 8.3M
- IPO Year
- VRAX 2022
- POLA 2016
- Fundamental
- Price
- VRAX $2.14
- POLA $3.17
- Analyst Decision
- VRAX
- POLA
- Analyst Count
- VRAX 0
- POLA 0
- Target Price
- VRAX N/A
- POLA N/A
- AVG Volume (30 Days)
- VRAX 487.9K
- POLA 75.1K
- Earning Date
- VRAX 02-05-2025
- POLA 11-14-2024
- Dividend Yield
- VRAX N/A
- POLA N/A
- EPS Growth
- VRAX N/A
- POLA N/A
- EPS
- VRAX N/A
- POLA N/A
- Revenue
- VRAX $84,872.00
- POLA $14,953,000.00
- Revenue This Year
- VRAX $5,169.18
- POLA $6.72
- Revenue Next Year
- VRAX $66.97
- POLA N/A
- P/E Ratio
- VRAX N/A
- POLA N/A
- Revenue Growth
- VRAX 7.03
- POLA N/A
- 52 Week Low
- VRAX $0.60
- POLA $2.24
- 52 Week High
- VRAX $9.00
- POLA $4.90
- Technical
- Relative Strength Index (RSI)
- VRAX 49.68
- POLA 50.84
- Support Level
- VRAX $2.03
- POLA $3.07
- Resistance Level
- VRAX $2.33
- POLA $3.34
- Average True Range (ATR)
- VRAX 0.39
- POLA 0.31
- MACD
- VRAX -0.04
- POLA -0.01
- Stochastic Oscillator
- VRAX 21.48
- POLA 45.05
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.